Featuring perspectives from Dr Andrew J Armstrong and Dr Scott T Tagawa, including the following topics:
- Introduction: Evolution of the Prostate Cancer Model; Prostate Cancer Working Group 4 (PCWG4) (0:00)
- Hormonal Therapy (5:48)
- Chemotherapy (Docetaxel) (26:38)
- PARP Inhibition (29:49)
- Radioligand Therapy (36:56)
- New Agents (43:37)